|
2017 Conference Publication Identifying Clinical Pharmacist Patient Prioritisation CriteriaFalconer, Nazanin, Barras, Michael and Cottrell, Neil (2017). Identifying Clinical Pharmacist Patient Prioritisation Criteria. Australasian Pharmaceutical Science Association (APSA) and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Joint Scientific Meeting, Brisbane QLD Australia, December 2017. |
|
2015 Conference Publication A Randomized Trial of Olanzapine and Palonosetron versus Infused Ondansetron for the Treatment of Chemotherapy Induced Nausea and Vomiting in Patients Undergoing Hematopoietic Stem Cell TransplantationNakagaki, Midori, Barras, Michael, Curley, Cameron, Butler, Jason P. and Kennedy, Glen A. (2015). A Randomized Trial of Olanzapine and Palonosetron versus Infused Ondansetron for the Treatment of Chemotherapy Induced Nausea and Vomiting in Patients Undergoing Hematopoietic Stem Cell Transplantation. 57th Annual Meeting of the American Society of Hematology, Orlando, FL United States, 5-8 December 2015. Washington, DC United States: American Society of Hematology. |
|
2013 Conference Publication Implementation and Evaluation of an Interprofessional CurriculumCottrell, Neil, Waller, Susan, Barras, Michael, Burston, Adam, Dickie, Robyn, Groves, Michele, Kendall, Bradley and Rylands, Linda (2013). Implementation and Evaluation of an Interprofessional Curriculum. Collaborating Across Borders III (CAB III) Interprofessional Collaboration: From Concept to Preparation to Practice, Tucson, AZ, United States, 19-21 November 2011. London, United Kingdom: Informa Healthcare. doi: 10.3109/13561820.2013.761518 |
|
2011 Conference Publication Comparison of one vs. two blood samples for determination of tobramycin AUC in children with cystic fibrosisNorris, R. L. G., Barras, M., Alraman, H., Kirkpatrick, C., Dakin, C., Harris, M. and Jess, K. (2011). Comparison of one vs. two blood samples for determination of tobramycin AUC in children with cystic fibrosis. 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Stuttgart, Germany, 2-6 October 2011. Philadelphia PA, United States: Lippincott Wiliams & Wilkins. doi: 10.1097/01.ftd.0000400651.94145.ba |
|
2009 Conference Publication The impact of an individualised medication information session on medication knowledge and quality of life of people with parkinson’s diseaseO’Maley, Karen A., O’Sullivan, John D., Wollin, Judy and Barras, Michael (2009). The impact of an individualised medication information session on medication knowledge and quality of life of people with parkinson’s disease. Australian and New Zealand Association of Neurologists (ANZAN) 2008 Annual Scientific Meeting, Australia, 2008. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jocn.2008.07.043 |
|
2009 Conference Publication A survey of therapeutic drug monitoring in AustralasiaNorris, Ross, Morris, Ray, Thompson, Erin, Ray, John, Barras, Michael, Jones, Graham and Martin, Jenny (2009). A survey of therapeutic drug monitoring in Australasia. 11th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Montréal, QC, Canada, 3-8 October 2009. New York, NY, U.S.A.: Lippincott-Raven. doi: 10.1097/FTD.0b013e3181b7997b |
|
2008 Conference Publication The evaluation of an individualised dosing strategy for enoxaparinBarras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). The evaluation of an individualised dosing strategy for enoxaparin. The 34th Society of Hospital Pharmacists of Australia (SHPA) National Conference, Adelaide Australia, September 2008. |
|
2008 Conference Publication Individualized compared with conventional dosing of enoxaparinBarras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). Individualized compared with conventional dosing of enoxaparin. Population Approach Group in Europe (PAGE) Conference, Marseille, France, June 2008. Leiden: Population Approach Group in Europe. |
|
2008 Conference Publication A survey of therapeutic drug monitoring in Australia and New ZealandNorris, R., Morris, R., Ray, J., Ilett, K.F., Fullinfaw, R., Lee, T., Martin, J., Barras, M., Thompson, E. M. and Jones, G. R. D. (2008). A survey of therapeutic drug monitoring in Australia and New Zealand. Australasian Association of Clinical Biochemists’ 45th Annual Scientific Conference, Adelaide, South Australia, 16-19 September 2008. Mt. Lawley, W.A., Australia: Australasian Association of Clinical Biochemists. |
|
2008 Conference Publication The evaluation of an individualised dosing strategy derived from population PK modelling and simulationBarras, M. A., Duffull, S. B., Atherton, J. J. and Green, B. (2008). The evaluation of an individualised dosing strategy derived from population PK modelling and simulation. Population Approach Group in Australia and New Zealand (PAGANZ) Conference, Dunedin, Otago, New Zealand, 13-15 February 2008. |
|
2007 Conference Publication Comparison of self reported myalgia in individuals on high and low to moderate dose statin therapyGujral, G., Barras, M. and Cottrell, W. N. (2007). Comparison of self reported myalgia in individuals on high and low to moderate dose statin therapy. Medicines: Design to Delivery. Manly 2007 2nd Annual Conference of The Australasian Pharmaceutical Science Association, Manly, NSW, Australia, 8-11 December 2007. Australian Pharmaceutical Science Association (APSA). |
|
2007 Conference Publication A Population PKPD Model for Bleeding Events with EnoxaparinBarras, M. A., Duffull, S., Atherton, J. and Green, B. (2007). A Population PKPD Model for Bleeding Events with Enoxaparin. 2007 AAPS Annual Meeting and Exposition, San Diego California, 11th-15th November, 2007. |
|
2004 Conference Publication Milk, bread and NSAIDs: The shopping list of 2004. Measuring the impact of open sale NSAIDs.Windsor, S.N., Barras, M. A. and Rofail, S. (2004). Milk, bread and NSAIDs: The shopping list of 2004. Measuring the impact of open sale NSAIDs.. SHPA Qld Branch Conference, Toowoomba, 16-18 July 2004. Australia: SHPA. |
